What Researchers Did
The researchers conducted a review of published English literature from Medline and PubMed to evaluate the current evidence for hyperbaric oxygen therapy as an adjunctive treatment for necrotizing fasciitis.
What They Found
The review revealed inconsistent results regarding the use of hyperbaric oxygen therapy for necrotizing fasciitis. Some studies indicated that HBO could improve patient survival and decrease the number of debridements required, while others failed to show any beneficial effect. Consequently, the evidence was not robust enough to recommend widespread or routine use.
What This Means for Canadian Patients
For Canadian patients diagnosed with necrotizing fasciitis, this review suggests that hyperbaric oxygen therapy may be an encouraging adjunctive treatment, but its effectiveness is not yet definitively established. Patients should discuss the potential role of HBO with their healthcare providers as part of a comprehensive treatment plan, acknowledging that further research is still needed.
Canadian Relevance
The study authors are not identified as Canadian, nor was the study conducted in Canada. However, necrotizing fasciitis is a serious condition recognized by Health Canada, and hyperbaric oxygen therapy is a recognized medical treatment for certain indications in Canada.
Study Limitations
This study is a literature review, meaning it synthesizes existing research rather than providing new primary data, and thus reflects the inconsistencies present in the published literature.